American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, DC: American Psychiatric Association; 2013.
2.
CanitanoR: Clinical experience with topiramate to counteract neuroleptic induced weight gain in 10 individuals with autistic spectrum disorders. Brain Dev, 27:228–232, 2005.
3.
CorrellCU, SikichL, ReevesG, RiddleM: Metformin for antipsychotic-related weight gain and metabolic abnormalities: when, for whom, and for how long?. Am J Psychiatry, 170:947–952, 2013.
4.
CurtinC, JojicM, BandiniLG: Obesity in children with autism spectrum disorder. Harv Rev Psychiatry, 22:93–103, 2014.
5.
DaumitGL, GoffDC, MeyerJM, DavisVG, NasrallahHA, McEvoyJP, RosenheckR, DavisSM, HsiaoJK, StroupTC, LiebermanJA: Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophr Res, 105:175–187, 2008.
6.
HardanAY, RogerJJ, HandenBL: A retrospective assessment of topiramate in children and adolescents with pervasive developmental disorders. J Child Adolesc Psychopharmacol, 14:426–432, 2004.
7.
McDougleCJ: Sounding a wake-up call: Improving the lives of adults with autism. J Am Acad Child Adolesc Psychiatry, 52:566–568, 2013.
8.
McDougleCJ, HolmesJP, CarlsonDC, PeltonGH, CohenDJ, PriceLH: A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch Gen Psychiatry, 55:633–641, 1998.
9.
PolitteLC, McDougleCJ: Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders. Psychopharmacology, 231:1023–1036, 2014.
RezaeiV, MohammadiMR, GhanizadehA, SahraianA, TabriziM, RezazadehSA, AkhondzadehS: Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry, 34:1269–1272, 2010.
12.
StiglerKA, PotenzaMN, PoseyDJ, McDougleCJ: Weight gain associated with atypical antipsychotic use in children and adolescents: Prevalence, clinical relevance, and management. Paediatr Drugs, 6:33–44, 2004.
